Soro autólogo para doenças da superfície ocular

Translated title of the contribution: Autologous serum for ocular surface diseases

Guilherme Goulart Quinto, Mauro Campos, Ashley Behrens

Research output: Contribution to journalArticlepeer-review

75 Scopus citations


Autologous serum has been used to treat dry eye syndrome for many years. It contains several growth factors, vitamins, fibronectin and other components that have been considered important for corneal and conjunctival integrity. Serum eye drops are usually prepared as an unpreserved blood solution. The serum is by nature well tolerated and its biochemical properties are somewhat similar to natural tears. Autologous serum eye drops have been reported to be effective for the treatment of severe dry eye-related ocular surface disorders (Sjögren's syndrome), and also other entities such as superior limbic keratoconjunctivitis, graft-versus-host disease, Stevens-Johnson syndrome, ocular cicatricial pemphigoid, recurrent or persistent corneal erosions, neurotrophic keratopathy, Mooren's ulcer, aniridic keratopathy, filtering blebs after trabeculectomy, and postkeratorefractive surgery. The purpose of this study is to review the recently published literature on ocular surface diseases treated with human autologous serum eye drops.

Translated title of the contributionAutologous serum for ocular surface diseases
Original languagePortuguese
Pages (from-to)47-54
Number of pages8
JournalArquivos brasileiros de oftalmologia
Issue number6 SUPP
StatePublished - 2009


  • Conjunctival diseases/therapy
  • Corneal diseases/therapy
  • Lacrimal apparatus/abnormalities
  • Ophthalmic solutions/therapeutic use
  • Serum

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Autologous serum for ocular surface diseases'. Together they form a unique fingerprint.

Cite this